Morocco adopts Covid-19 Molnopiravir drug, in anticipation of its authorization by the FDA

Morocco adopts Covid-19 Molnopiravir drug, in anticipation of its authorization by the FDA
Tuesday 23 November 2021 - 10:21

Morocco is moving towards adopting the Covid-19 drug Molonoperavir, in order to diversify its Covid-19 medical treatment and control the epidemiological situation in the Kingdom, said an official source to Hespress.

“Morocco decided to adopt the drug molonoperavir, which has proven its effectiveness, as scientific studies indicate that it was able to successfully bypass the experimental stages and achieve good results,” said the source.

Two years through the pandemic, American company Merck and its partner Ridgeback Therapeutics produced the drug “Molnopiravir,” which would fill a gap in the medical treatment of Covid-19 patients, if it gets approved by the US Food and Drug Administration by the end of November.

Meanwhile, Morocco has already reached purchasing agreements with the producing company in anticipation of its authorization, said the source.

Mustapha Naji, an expert in virology at the Faculty of Medicine at Hassan II University in Casablanca, told Hespress that “Molnopiravir can prevent the complications of the virus among the infected, and it is a preventive antidote that will protect people who have contracted the virus,” adding that “all scientific studies have proven its effectiveness.”

Professor Azeddine El Ibrahimi, a member of the Scientific Advisory Committee, said that “Molnopiravir” can be taken at home orally after a positive PCR, with no need to go to the hospital.

“Merk” research says that Molnupiravir reduced the risk of death or hospitalization by about 50% in non-hospitalized adult patients with mild to moderate COVID-19 when treated within five days of symptom onset.
An advisory committee to the Food and Drug Administration plans to review the data supporting Molnupiravir on Nov. 30, 2021.

Morocco, which recently lifted its night curfew, fears of a new Covid-19 wave are rising as the rate of vaccination decreased in the last weeks amid the controversy of the mandatory vaccine pass and the booster shots.

add your comment

Terms of publication : Not to offend the writer, people, sacred things, or attack religions or the divine self, and refrain from racist incitement and insults.

Economy
Morocco’s defense industry roadmap targets 50,000 jobs and 65% export revenue by 2035
Thursday 19 November 2026 - 00:00

Morocco’s defense industry roadmap targets 50,000 jobs and 65% export revenue by 2035

News
Mohammed VI International university hospital complex inaugurated in Dakhla
Wednesday 18 November 2026 - 22:00

Mohammed VI International university hospital complex inaugurated in Dakhla

News
Dutch lawmakers challenge Google over racist search suggestions targeting Moroccans
Wednesday 18 November 2026 - 20:00

Dutch lawmakers challenge Google over racist search suggestions targeting Moroccans

Economy
Morocco’s GDP per capita set to exceed $5,000 for first time in 2026, IMF forecasts
Wednesday 18 November 2026 - 18:00

Morocco’s GDP per capita set to exceed $5,000 for first time in 2026, IMF forecasts